Amgen Set to Buy Onyx Pharmaceuticals

Aug. 26 (Bloomberg) -- Bloomberg’s Drew Armstrong discusses the latest major pharmaceutical deal with Amgen set to purchase Onyx. He speaks with Stephanie Ruhle and Tom Keene on Bloomberg Television’s “Market Makers.” (Source: Bloomberg)
Sternlicht: Real Estate Market Best to Invest In
36:23 - Starwood Capital Group Chairman and CEO Barry Sternlicht discusses hedge funds and the real estate market. He speaks on "Bloomberg ‹GO›." (Source: Bloomberg)
  • Barry Sternlicht Explains Investment Outlook
  • U.S. Banker Frontrunner to Fill Barclays’s CEO Vacuum
  • SABMiller Sold in Principle to AB InBev for $106 Billion